Skip to main content
Equibles

Yugal Nokomovic

Analyst

Citigroup

Equibles does not estimate personal net worth.

About Yugal Nokomovic

Yugal Nokomovic is recorded as Analyst at Citigroup. Yugal Nokomovic has spoken on 1 earnings call across 1 company, most recently for Neurocrine Biosciences Inc on February 11, 2026. The companies whose calls Yugal Nokomovic spoke on are classified in the Healthcare sector.

Yugal Nokomovic on recent calls

“I just wanted to probe a little further on the 10% share in CAH. Is it correct that that's all endos? Are you seeing any early share from some of the other categories you mentioned, like PCPs and OBGYN?”
Analyst — Citigroup, Neurocrine Biosciences Inc Q4 FY2025 Earnings Call ·

Affiliation history

  • Citigroup

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity